NIH-funded research R01 grant

How Gut Bacteria Affect Hair Loss in Alopecia Areata

Official title: Influence of the Microbiome on the Natural History of Alopecia Areata

Funded at Columbia University Health Sciences · NIH-10814252 · Data updated 2026-11-12

This project explores how the bacteria in our gut might influence the progression of alopecia areata, a condition that causes hair loss.

More Alopecia Areata research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2023
Project endFebruary 28, 2028
Funding year2025
Award (this year)$195,426
NIH project number5R01AR079744-02
Project IDNIH-10814252 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with alopecia areata, including those with patchy hair loss, total scalp hair loss, or total body hair loss, may be ideal candidates for future related studies.

Less likely to help

Patients whose hair loss is not related to an autoimmune condition or the gut microbiome may not receive direct benefit from this specific line of inquiry.

What this research studies

Alopecia areata is an autoimmune condition where the body's immune system mistakenly attacks hair follicles, leading to hair loss. While genetics play a role, environmental factors are also important, and this project focuses on the gut microbiome as a potential trigger. We aim to understand how the complex community of bacteria in the intestines might affect the immune system and contribute to the development or worsening of alopecia areata. By looking at how these gut bacteria change over time, we hope to uncover new insights into this condition.

Why it matters

Potential benefit: If successful, this work could lead to new ways to prevent or treat alopecia areata by targeting the gut microbiome.

How similar studies have gone: While the gut microbiome is increasingly linked to autoimmune diseases, this project is novel in its focus on longitudinal studies specifically for alopecia areata.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Christiano, Angela M — Columbia University Health Sciences
  • Study coordinator: Christiano, Angela M

Related research

Other NIH-funded projects on the same topics.

  • Dupilumab for hair regrowth in children with alopecia areata

    This project gives dupilumab to children and teens with widespread alopecia areata, especially those with allergies or high IgE, to help their hair grow back.

    NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11322610

  • Targeting the NKG2A immune pathway to treat alopecia areata

    This project will try blocking the NKG2A immune signal to reduce the immune attack on hair follicles and help people with alopecia areata regrow hair.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11294331

  • How IL-27 affects hair loss in alopecia areata

    Researchers are exploring whether the immune molecule IL-27 helps stop the immune attack that causes hair loss in people with alopecia areata.

    NIH research University of Iowa · Iowa City, United States · NIH-11177806

  • Using hydrogels to treat hair loss in alopecia areata

    This study is exploring a new gel treatment for people with alopecia areata, a condition that causes hair loss, to see if it can help stimulate hair regrowth in a safe and effective way.

    NIH research University of Pennsylvania · Philadelphia, United States · NIH-11136601

  • Using dupilumab to treat hair loss in children with alopecia areata

    This study is looking at how a medication called dupilumab can help kids with alopecia areata, a condition that causes hair loss, by encouraging hair regrowth and making sure the treatment is safe and effective for them.

    NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11089294

  • Investigating the NKG2A pathway to treat hair loss in alopecia areata

    This study is looking at alopecia areata, a condition that causes hair loss, and is exploring new ways to help by targeting certain immune cells; if you're dealing with this condition, you might have a chance to join trials testing these exciting new treatments.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11051236

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.